Immunoassay Market Overview, Segmentation, Outlook And Trends Report 2033

"The new report published by The Business Research Company, titled ""Immunoassay Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the immunoassay market size has grown strongly in recent years. It will grow from $34.75 billion in 2023 to $36.79 billion in 2024 at a compound annual growth rate (CAGR) of 5.9%. The immunoassay market size is expected to see strong growth in the next few years. It will grow to $47.01 billion in 2028 at a compound annual growth rate (CAGR) of 6.3%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=9838&type=smp

Rising Infectious And Chronic Diseases Drive Immunoassay Market Growth
The increasing numbers of infectious and chronic illnesses are expected to propel the growth of the immunoassay market in the coming future. Chronic illnesses are characterized generically as those that persist for a year or more, need continuous medical care, restrict everyday activities, or both. Infectious illnesses are ailments caused by organisms such as bacteria, viruses, fungi, or parasites. Numerous creatures inhabit and dwell on the human body. Several infectious illnesses can be transmitted from person to person. Immunoassay is employed to detect several infectious and chronic diseases. For instance, according to a report published by the National Institutes of Health (NIH), a US-based biomedical research agency, in 2023, in the United States, the number of people aged 50 and older with at least one chronic illness is predicted to rise by 99.5%, from 71.522 million in 2020 to 142.66 million in 2050. Additionally, the number of people with multimorbidity would rise by 91.16% from 7.8304 million in 2020 to 14.968 million in 2050. Therefore, the increasing number of infectious and chronic illnesses is driving the market.

Product Innovation Reshapes Immunoassay Market Landscape
Product innovation is the key trend gaining popularity in the immunoassay market. Major companies operating in the immunoassay market are focused on developing innovative products to strengthen their position in the market. For instance, in November 2022, Getein Biotech Inc., a China-based biotechnological company involved in the manufacturing, sales, service, and research and development of in vitro diagnostic reagents and tools, launched MAGICL 6000 at MEDICA 2022. MAGICL 6000 is a portable, cutting-edge chemiluminescence immunoassay analyzer that is the best option for labs with mid- to high-workflow requirements for a one-step chemiluminescence solution. The instrument is extremely efficient and small, allows for completely automated operation, and has the quickest assessment frequency of any device of its size.

The immunoassay market covered in this report is segmented -

1) By Product: Reagents And Kits, Analyzers Or Instruments, Software And Services
2) By Specimen: Blood, Saliva, Urine, Other Specimens
3) By Application: Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications
4) By End User: Research And Academic Laboratories, Home Care Settings, Pharmaceutical And Biotechnology Companies And CROs, Blood Banks, Hospitals And Clinics, Clinical Laboratories

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=9838&type=discount

Major companies operating in the immunoassay market report are Siemens Healthineers GmbH, bioMérieux, Abbott, Beckman Coulter Inc., Quidel Corporation, Ortho Clinical Diagnostics, Sysmex Corporation, Bio-Rad Laboratories Inc., Becton Dickinson and Company, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc, WAK-Chemie Medical GmbH, J Mitra & Co Pvt Ltd, Kamiya Biomedical Company, Tosoh Corporation, Gyros Protein Technologies AB, BioCheck Inc., Bio-Techn, DiaSorin S.p.A, Meso Scale Diagnostics LLC, QIAGE, Randox Laboratories Ltd., Shenzhen Mindray Bio-Medical Electronics Co Ltd, Danaher Corporation, Hologic Inc., Tecan Trading AG, Eurofins Scientific, Abcam plc, Enzo Biochem Inc., Luminex Corporation, Quanterix Corporation, Roche Diagnostics, Waters Corporation, ZEUS Scientific Inc. .

Contents of the report:
1. Executive Summary
2. Immunoassay Market Report Structure
3. Immunoassay Market Trends And Strategies
4. Immunoassay Market - Macro Economic Scenario
5. Immunoassay Market Size And Growth
…..
27. Immunoassay Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/immunoassay-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

"Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide."

This release was published on openPR.